Addressing the traffic safety issues caused by pedestrian-vehicle conflicts during street crossing, this study proposes optimization strategies from both theoretical and technical perspectives. A safety braking distance model is introduced, taking into account pedestrians' psychological safety and vehicle braking processes. Additionally, an active safety warning system for crosswalks has been designed. This system features a modular design, including detection, control, alarm, and wireless communication modules. It can monitor, in real-time, the positions and speeds of pedestrians and vehicles, assess potential conflicts between them under various scenarios, and implement different warning strategies accordingly. Compared to mainstream variable message sign (VMS) warning systems, this proposed system shows significant advantages in terms of section-weighted total delay metrics. Through simulations involving 3000 pedestrian crossings and comparative analyses of vehicle speed, pedestrian speed, vehicle deceleration rate, and accident numbers before and after the application of the active safety warning system, it was found that the critical accident rate indicator decreased from 0.27% to 0.06%. The results demonstrate that the system effectively provides bidirectional warnings to pedestrians and vehicles, significantly enhancing the safety of pedestrian street crossings. This research offers new insights into addressing pedestrian crossing safety issues.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11859144PMC
http://dx.doi.org/10.3390/s25041100DOI Listing

Publication Analysis

Top Keywords

active safety
12
safety warning
12
warning system
12
braking distance
8
safety
8
pedestrian crossings
8
safety issues
8
pedestrians vehicles
8
pedestrian
6
system
6

Similar Publications

The discovery of novel, selective inhibitors targeting CDK2 and PIM1 kinases, which regulate cell survival, proliferation, and treatment resistance, is crucial for advancing cancer therapy. This study reports the design, synthesis, and biological evaluation of three novel pyrazolo[3,4-]pyridine derivatives (), confirmed spectral analyses. These compounds were assessed for anti-cancer activity against breast, colon, liver, and cervical cancers using the MTT assay.

View Article and Find Full Text PDF

Purpose: To evaluate and contrast the effectiveness and safety of two conbercept treatment protocols-a three-dose treat-and-extend (3+T&E) regimen and a three-dose pro re nata (3+PRN) regimen-in Chinese patients diagnosed with neovascular age-related macular degeneration (nAMD).

Methods: Eligible patients, who had not undergone anti-VEGF intraocular injections within 3 months prior to enrollment, were randomly assigned to either the 3+T&E or 3+PRN regimen. The 3+T&E group received at least three monthly injections, with subsequent visit intervals extended based on disease activity assessment.

View Article and Find Full Text PDF

This research paper presents the characterization of an enterocin-producing MF5 isolate and the determination of the in vitro antilisterial activity of enterocin produced by this isolate, named Ent-MF5. PCR-based screening for bacteriocin biosynthetic genes revealed that MF5 harbors multiple enterocin-encoding genes ( A, B, P and X), classified as class II bacteriocins and enterocin-P of (sharing up to 99% similarity at the genetic level). MF5 is sensitive to eight clinically important antibiotics and does not possess cytolysin activator -A, gelatinase -E and hyaluronidase -lA virulence genes.

View Article and Find Full Text PDF

Introduction: The aim of this study is to investigate the effects of supplementing () on hybrid grouper ( ♀ × ♂), with a particular focus on its impact on growth performance, blood composition, intestinal antioxidant capacity, gut microbiota, tight junction protein (ZO-1) expression, and inflammatory gene expression. The study seeks to uncover the potential health benefits of C. butyricum supplementation for hybrid grouper.

View Article and Find Full Text PDF

Background And Objective: For treating community-acquired pneumonia (CAP) in adults, early switching from injectable to oral antimicrobials (switch therapy) is accepted once the clinical course is favorable. Lascufloxacin (LSFX) is a quinolone antibacterial agent, available in intravenous and oral formulations, demonstrating antibacterial activity against a relatively broad spectrum of community-onset pneumonia (COP). No switch therapy using the same drug from injectable to oral antimicrobials has been reported; therefore, we conducted the study to confirm the efficacy and safety of the switch therapy using LSFX.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!